Codarri Deak, Laura http://orcid.org/0000-0002-9913-9285
Nicolini, Valeria
Hashimoto, Masao http://orcid.org/0000-0002-7120-1390
Karagianni, Maria
Schwalie, Petra C.
Lauener, Laura
Varypataki, Eleni Maria
Richard, Marine
Bommer, Esther
Sam, Johannes http://orcid.org/0000-0002-7455-0609
Joller, Stefanie
Perro, Mario
Cremasco, Floriana
Kunz, Leo
Yanguez, Emilio
Hüsser, Tamara
Schlenker, Ramona
Mariani, Marisa
Tosevski, Vinko
Herter, Sylvia
Bacac, Marina
Waldhauer, Inja http://orcid.org/0000-0001-8008-8660
Colombetti, Sara
Gueripel, Xavier
Wullschleger, Stephan http://orcid.org/0000-0002-5521-2276
Tichet, Melanie http://orcid.org/0000-0001-7128-4061
Hanahan, Douglas
Kissick, Haydn T. http://orcid.org/0000-0001-7624-5598
Leclair, Stephane
Freimoser-Grundschober, Anne http://orcid.org/0000-0001-5715-3639
Seeber, Stefan
Teichgräber, Volker
Ahmed, Rafi http://orcid.org/0000-0002-9591-2621
Klein, Christian http://orcid.org/0000-0001-7594-7280
Umaña, Pablo http://orcid.org/0000-0001-8206-2771
Article History
Received: 14 March 2021
Accepted: 4 August 2022
First Online: 28 September 2022
Competing interests
: Patent application number 15/943,237, with relevance to this work, has been filed by Roche. L.C.D., C.K., L.L., V.N., S.S., I.W. and P.U. are named inventors on this patent family. R.A. holds patents related to the PD-1 pathway. H.K., M.H. and R.A. declare no additional financial interests. L.C.D., V.N., M.K., P.S., L.L., E.M.V., M.R., E.B., J.S., S.J., F.C., M.P., L.K., E.Y., T.H., R.S., M.M., V. Tosevski, S.H., M.B., I.W., S.C., X.G., S.L., A.F.-G., S.S., V. Teichgräber, C.K. and P.U. are employees of Roche and declare ownership of Roche stock. Work performed at Emory for this manuscript was supported by the Roche pRED ROADS program.